Overview of Merck & Co., Inc. (MRK) Merck & Co., Inc. (NYSE: MRK) is a global pharmaceutical leader known for blockbuster drugs like Keytruda and Gardasil. With a rich history of dividend growth, Merck has long been a staple for dividend-focused investors. Recently, the company has faced headwinds, causing a sharp decline in its Continue reading →
Making 45% Annually Trading Options Against Dividend Growth Stocks
Archive for February, 2025
Dividend Growth & Value Stocks for February 2025
Dear Investors, Welcome to this edition of the Dividend Growth & Value Newsletter—your trusted source for identifying undervalued dividend stocks with strong growth potential while avoiding common dividend traps. This month’s focus is on stocks yielding 3.5% or more, offering sustainable growth, and trading at attractive valuations. The following five picks stand out as solid Continue reading →
Futures opened down -1.85% on trade war fears.
So, our convicted felon did it once again. Americans didn’t learn their lesson in 2018 and they need to re-live the shit show once again. Today (Sunday, February 2nd, 2025) the furues opened down -1.85% on trade wars fear as I was afraid it would happen. On Friday, I finished trading with the following position: Continue reading →
Donnie is f-ing it up again
So Donnie is on it again. It is astounding how ignorant he is. Or he is not and all this tariff thing is on purpose. No matter how hard I try to think about what is he trying to achieve, I cannot come up with any idea on “why.” Trump negotiated a trade treaty during Continue reading →
Recent Comments